The Addiction Treatment Best Practice Question

I was surprised to learn that the use of medication-assisted treatment (MAT) for addiction treatment in members of commercial health plans is significantly less than use of MAT among Medicaid health plan members. That was a key takeaway from the recent keynote session lead by David Lederman, Senior Product Manager for Elevance Health, Behavioral Health Advantage – The Elevance Health Approach To Innovations In Substance Use & Suicide Prevention at The 2023 OPEN MINDS Strategy & Innovation Institute.

I had assumed that use of these medications, accepted ‘best practice’ in the addiction treatment, would be greater among the population of . . .